Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer

NCT00155896 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00155896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00155896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2003
Completion date
December 31, 2008
Enrollment
100
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian cancer